1) Findings: Insights and developments globally on the subject of cancer.
2) Companies: Updates and progress reports on Consortium member companies.
3) Industry: Important developments from throughout the field of cancer.
A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI’s National […]
Nanostics Inc. is a medical device and biotechnology company based in Alberta, Canada. They are focused on developing a highly accurate test to predict clinically significant prostate cancer. Their core technology, ClarityDX, […]
September is Ovarian Cancer Awareness Month, highlighting a disease that kills nearly 15,000 women annually out of the 21,000 diagnosed. Relatively uncommon as cancers go, ovarian cancer nevertheless causes the most deaths […]
Genomics, the branch of molecular biology concerned with the structure, function, evolution, and mapping of an individual’s genes, is already revolutionizing the way medicine treats cancer. Like many sciences, genomics has “niches;” single-cell genomics […]
Minomic, a Sydney-based diagnostic company, has developed an in vitro diagnostic test for the early detection of prostate cancer. Their product, MiCheck®, is a blood test that uses their patented monoclonal antibody […]
A new combination of two standing drugs and radiation therapy has the potential to revolutionize the treatment and care of pancreatic cancer, one of the most lethal diagnoses an oncologist can face […]
Cancer is an inherently confusing disease. Such a diagnosis can overwhelm an individual with a myriad of questions. Sometimes these questions pour out, one after another. Other times, the stream of questions […]
Approved by the FDA in 1993, the drug cladribine offered hope for the then-fatal blood cancer called hairy cell leukemia, or HCL, and was soon expanded as a therapy for multiple sclerosis. Developed by […]
